Udg Healthcare PLC PT Raised to GBX 400 (UDG)
Analysts at Jefferies Group increased their target price on shares of Udg Healthcare PLC (LON:UDG) from GBX 385 ($6.48) to GBX 400 ($6.74) in a research report issued to clients and investors on Wednesday, AnalystRatingsNetwork.com reports. The firm currently has a “buy” rating on the stock. Jefferies Group’s price target would indicate a potential upside of 11.11% from the company’s current price.
Udg Healthcare PLC (LON:UDG) opened at 367.00 on Wednesday. Udg Healthcare PLC has a 52-week low of GBX 293.30 and a 52-week high of GBX 380.10. The stock’s 50-day moving average is GBX 356.7 and its 200-day moving average is GBX 340.7. The company’s market cap is £885.6 million.
Other equities research analysts have also recently issued reports about the stock. Analysts at Goodbody Stockbrokers Ltd reiterated a “buy” rating on shares of Udg Healthcare PLC in a research note on Wednesday. Separately, analysts at Investec raised their price target on shares of Udg Healthcare PLC from GBX 305 ($5.14) to GBX 360 ($6.06) in a research note on Wednesday. They now have a “hold” rating on the stock. Finally, analysts at N 1 Singer reiterated a “buy” rating on shares of Udg Healthcare PLC in a research note on Wednesday. They now have a GBX 410 ($6.91) price target on the stock. One equities research analyst has rated the stock with a hold rating and six have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of GBX 386 ($6.50).
UDG Healthcare plc is an international provider of services to healthcare manufacturers and pharmaceutical retailers, with operations in over 20 countries including the United States, the United Kingdom, Ireland, Germany, the Netherlands and Belgium.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.